120 related articles for article (PubMed ID: 2895108)
1. Neurogenic vasodilatation produced by fenoldopam in the rat hindquarters vascular bed.
Van der Niepen P; Lefebvre RA; Dupont AG
J Auton Pharmacol; 1987 Dec; 7(4):331-8. PubMed ID: 2895108
[TBL] [Abstract][Full Text] [Related]
2. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
Dupont AG; Lefebvre RA; Vanderniepen P
Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat.
Van der Niepen P; Schoors DF; Dupont AG
Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774
[TBL] [Abstract][Full Text] [Related]
4. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
5. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
Lokhandwala MF; Watkins HO; Dlewati A
Eur J Pharmacol; 1987 Nov; 143(3):383-90. PubMed ID: 2891555
[TBL] [Abstract][Full Text] [Related]
6. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
Kohli JD; Glock D; Goldberg LI
J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
[TBL] [Abstract][Full Text] [Related]
7. Effect of quinpirole on neurogenic vasoconstriction in the in situ autoperfused hindquarters and renal vascular beds of the rat.
Roquebert J; Moran A; Demichel P
J Auton Pharmacol; 1992 Oct; 12(5):291-8. PubMed ID: 1358890
[TBL] [Abstract][Full Text] [Related]
8. Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.
Lappe RW; Todt JA; Wendt RL
J Pharmacol Exp Ther; 1986 Jan; 236(1):187-91. PubMed ID: 2867214
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
Sengupta S; Lokhandwala MF
J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
[TBL] [Abstract][Full Text] [Related]
10. Renal vasodilatation by dopexamine and fenoldopam due to alpha 1-adrenoceptor blockade.
Martin SW; Broadley KJ
Br J Pharmacol; 1995 May; 115(2):349-55. PubMed ID: 7670737
[TBL] [Abstract][Full Text] [Related]
11. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
Lokhandwala MF; Sabouni MH
J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
[TBL] [Abstract][Full Text] [Related]
12. The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro.
Hughes A; Thom S; Martin G; Redman D; Hasan S; Sever P
Br J Clin Pharmacol; 1986 Nov; 22(5):535-40. PubMed ID: 2878679
[TBL] [Abstract][Full Text] [Related]
13. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
Grega GJ; Barrett RJ; Adamski SW; Lokhandwala MF
J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
[TBL] [Abstract][Full Text] [Related]
14. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
Polak MJ; Taylor DA
Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
[TBL] [Abstract][Full Text] [Related]
16. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM
Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
Sabouni MH; Alkadhi KA; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216
[TBL] [Abstract][Full Text] [Related]
19. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
McCoy CE; Douglas FL; Goldberg LI
Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
[TBL] [Abstract][Full Text] [Related]
20. Atypical antagonism of D1-receptor-mediated vasodilator response in the perfused kidney by SCH23390.
Martin SW; Broadley KJ
Pharmacol Res; 1995 May; 31(5):289-97. PubMed ID: 7479526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
